Imbert-Teboul M, Champigneulle A
Laboratoire de Biologie Intégrée des cellules rénales, CNRS URA 1859, CEA, Centre d'Etudes de Saclay, DBCM, SBCe, Gif-sur-Yvette.
C R Seances Soc Biol Fil. 1995;189(2):151-67.
In vitro studies on single microdissected segments have been extensively used during the 20 past years to localize V1 and V2 vasopressin receptors within the mammalian kidney, and define their role in the control of water balance. Based on vasopressin-dependent adenylate cyclase activity measurements and quantitative RT-PCR studies, it is now clear that V2 receptors are present along the whole collecting duct from cortex to papilla, and, in most species, in the ascending limb of Henle's loop (thick and thin limb); occasionally in the distal tubule but not in the other segments. The stimulation by cyclic AMP of sodium chloride reabsorption in the thick ascending limb, and of urea reabsorption in the papillary collecting duct indicates that vasopressin--in addition to its well known hydroosmotic effect--also participates in the building up of the corticopapillary gradient of osmotic pressure. As regards the V1a receptor, binding studies as well as quantitative RT-PCR, and measurements of free cytosolic calcium concentration allow us to draw the following conclusions. In the rat, the V1a receptor is absent from the glomerulus, the proximal tubule (convoluted and straight portions), the tick ascending limb of Henle's loop and the terminal portion of the papillary collecting duct. It is present in the thin ascending limb and the cortical and outer medullary portions of the collecting duct. Its presence in the thin descending limb has not, up to now, been explored. By contrast with previous data in the rabbit, the V1a receptor does not alter vasopressin-dependent sodium and water reabsorption in the rat cortical collecting duct. Further studies will be necessary to determine its functional role in that segment, as well as in the thin ascending limb. Finally, vasopressin V2 agonists have been shown to induce intracellular calcium release in the papillary collecting duct, a segment devoid of V1a receptors. This effect--which cannot be ascribed to a cross-reaction with oxytocic receptors--indicates either an unusual coupling of the V2 receptor to phospholipase C or, else, the presence of a new vasopressin receptor.
在过去20年中,对单个显微切割节段的体外研究已被广泛用于在哺乳动物肾脏中定位V1和V2血管加压素受体,并确定它们在水平衡控制中的作用。基于对血管加压素依赖性腺苷酸环化酶活性的测量以及定量逆转录聚合酶链反应(RT-PCR)研究,现在已经明确,V2受体存在于从皮质到乳头的整个集合管中,并且在大多数物种中,存在于亨氏袢升支(粗段和细段);偶尔存在于远曲小管,但不存在于其他节段。环磷酸腺苷(cAMP)对厚壁升支中氯化钠重吸收以及乳头集合管中尿素重吸收的刺激表明,血管加压素除了其众所周知的水渗透作用外,还参与了皮质乳头渗透压梯度的形成。关于V1a受体,结合研究以及定量RT-PCR和游离细胞质钙浓度的测量使我们能够得出以下结论。在大鼠中,肾小球、近端小管(曲部和直部)、亨氏袢厚壁升支和乳头集合管末端部分不存在V1a受体。它存在于细段升支以及集合管的皮质和外髓部分。到目前为止,尚未研究其在细段降支中的存在情况。与先前在兔子中的数据相反,V1a受体不会改变大鼠皮质集合管中血管加压素依赖性钠和水的重吸收。需要进一步研究以确定其在该节段以及细段升支中的功能作用。最后,血管加压素V2激动剂已被证明可在乳头集合管中诱导细胞内钙释放,该节段缺乏V1a受体。这种效应——不能归因于与催产素受体的交叉反应——表明要么V2受体与磷脂酶C存在异常偶联,要么存在一种新的血管加压素受体。